Botulinum neurotoxin A for benign prostatic hyperplasia.

Abstract

PURPOSE OF REVIEW The injection of botulinum neurotoxin A (BoNT-A) into the prostate represents an alternative, minimal invasive treatment for lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH), which gained the interest of urologists during the last years, although it is not yet licensed. The purpose of this review is to… (More)
DOI: 10.1097/MOU.0b013e328333ac01

Topics

4 Figures and Tables

Cite this paper

@article{Oeconomou2010BotulinumNA, title={Botulinum neurotoxin A for benign prostatic hyperplasia.}, author={Athanassios Oeconomou and Helmut G Madersbacher}, journal={Current opinion in urology}, year={2010}, volume={20 1}, pages={28-36} }